Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research Biochemicals, Inc., 34651 [2020-12180]
Download as PDF
<![CDATA[
34651
Federal Register / Vol. 85, No. 109 / Friday, June 5, 2020 / Notices
(iv) indicate whether complainant,
complainant’s licensees, and/or third
party suppliers have the capacity to
replace the volume of articles
potentially subject to the requested
exclusion order and/or a cease and
desist order within a commercially
reasonable time; and
(v) explain how the requested
remedial orders would impact United
States consumers.
Written submissions on the public
interest must be filed no later than by
close of business, eight calendar days
after the date of publication of this
notice in the Federal Register. There
will be further opportunities for
comment on the public interest after the
issuance of any final initial
determination in this investigation. Any
written submissions on other issues
must also be filed by no later than the
close of business, eight calendar days
after publication of this notice in the
Federal Register. Complainant may file
replies to any written submissions no
later than three calendar days after the
date on which any initial submissions
were due. Any submissions and replies
filed in response to this Notice are
limited to five (5) pages in length,
inclusive of attachments.
Persons filing written submissions
must file the original document
electronically on or before the deadlines
stated above and submit 8 true paper
copies to the Office of the Secretary by
noon the next day pursuant to § 210.4(f)
of the Commission’s Rules of Practice
and Procedure (19 CFR 210.4(f)).
Submissions should refer to the docket
number (‘‘Docket No. 3457’’) in a
prominent place on the cover page and/
or the first page. (See Handbook for
Electronic Filing Procedures, Electronic
Filing Procedures 1). Persons with
questions regarding filing should
contact the Secretary (202–205–2000).
Any person desiring to submit a
document to the Commission in
confidence must request confidential
treatment. All such requests should be
directed to the Secretary to the
Commission and must include a full
statement of the reasons why the
Commission should grant such
treatment. See 19 CFR 201.6. Documents
for which confidential treatment by the
Commission is properly sought will be
treated accordingly. All information,
including confidential business
information and documents for which
confidential treatment is properly
sought, submitted to the Commission for
purposes of this Investigation may be
disclosed to and used: (i) By the
Commission, its employees and Offices,
and contract personnel (a) for
developing or maintaining the records
of this or a related proceeding, or (b) in
internal investigations, audits, reviews,
and evaluations relating to the
programs, personnel, and operations of
the Commission including under 5
U.S.C. Appendix 3; or (ii) by U.S.
government employees and contract
personnel,2 solely for cybersecurity
purposes. All nonconfidential written
submissions will be available for public
inspection at the Office of the Secretary
and on EDIS.3
This action is taken under the
authority of section 337 of the Tariff Act
of 1930, as amended (19 U.S.C. 1337),
and of §§ 201.10 and 210.8(c) of the
Commission’s Rules of Practice and
Procedure (19 CFR 201.10, 210.8(c)).
SUPPLEMENTARY INFORMATION:
By order of the Commission.
Issued: June 1, 2020.
Lisa Barton,
Secretary to the Commission.
Drug Enforcement Administration
Controlled substance
JWH–018 (also known as
AM678) 7118 I N 1-Pentyl3-(1-naphthoyl)indole.
lotter on DSK9F5VC42PROD with NOTICES
18:21 Jun 04, 2020
Jkt 250001
BILLING CODE 7020–02–P
[FR Doc. 2020–12180 Filed 6–4–20; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Bulk Manufacturer of Controlled
Substances Application: Chemtos,
LLC
ACTION:
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–659]
Bulk Manufacturer of Controlled
Substances Application: Sigma Aldrich
Research Biochemicals, Inc.
Notice of application.
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 4, 2020.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
Notice of application.
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 4, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
DATES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on May 7, 2020, Chemtos,
LLC, 16713 Picadilly Court, Round
Rock, Texas 78664–8544, applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substances:
SUPPLEMENTARY INFORMATION:
Drug code
2 All contract personnel will sign appropriate
nondisclosure agreements.
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
I
William T. McDermott,
Assistant Administrator.
3-Fluoro-N-methylcathinone (3–FMC) .............................................................................................................................
Cathinone ........................................................................................................................................................................
Methcathinone .................................................................................................................................................................
VerDate Sep<11>2014
7118
Schedule
The company plans to manufacture
small quantities of the listed controlled
substance to make reference standards
for distribution to its customers.
Controlled substance
1 Handbook for Electronic Filing Procedures:
https://www.usitc.gov/documents/handbook_on_
filing_procedures.pdf.
Drug
code
[Docket No. DEA–655]
[FR Doc. 2020–12151 Filed 6–4–20; 8:45 am]
ACTION:
In
accordance with 21 CFR 1301.33(a), this
is notice that on May 4, 2020, Sigma
Aldrich Research Biochemicals, Inc.,
400–600 Summit Drive, Burlington,
Massachusetts 01803, applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substance:
1233
1235
1237
Schedule
I
I
I
3 Electronic Document Information System
(EDIS): https://edis.usitc.gov.
E:\FR\FM\05JNN1.SGM
05JNN1
]]>Agencies
[Federal Register Volume 85, Number 109 (Friday, June 5, 2020)]
[Notices]
[Page 34651]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-12180]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-659]
Bulk Manufacturer of Controlled Substances Application: Sigma
Aldrich Research Biochemicals, Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before August 4, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on May 4, 2020, Sigma Aldrich Research Biochemicals,
Inc., 400-600 Summit Drive, Burlington, Massachusetts 01803, applied to
be registered as a bulk manufacturer of the following basic class(es)
of controlled substance:
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
JWH-018 (also known as AM678) 7118 I N 7118 I
1-Pentyl-3-(1-naphthoyl)indole.
------------------------------------------------------------------------
The company plans to manufacture small quantities of the listed
controlled substance to make reference standards for distribution to
its customers.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-12180 Filed 6-4-20; 8:45 am]
BILLING CODE 4410-09-P
